Adaptive Biotechnologies is trading 4.01% up at $25.93, but no clear company-specific announcement dated August 10, 2026 was identified.
- Recent reporting highlighted second-quarter revenue growth and raised MRD guidance.
- An August 4 Piper Sandler price-target increase may support sentiment, but neither directly explains the August 10 move; broader markets are mixed and the immediate catalyst remains uncertain.